![SAMSUNG Galaxy A13 5G Cell Phone, Factory Unlocked Android Smartphone, 64GB, Triple Lens Camera, Infinity Display Screen, Long Battery Life, Expandable Storage, US Version, Black SAMSUNG Galaxy A13 5G Cell Phone, Factory Unlocked Android Smartphone, 64GB, Triple Lens Camera, Infinity Display Screen, Long Battery Life, Expandable Storage, US Version, Black](https://m.media-amazon.com/images/I/61PkHEMqZfL._AC_UF894,1000_QL80_.jpg)
SAMSUNG Galaxy A13 5G Cell Phone, Factory Unlocked Android Smartphone, 64GB, Triple Lens Camera, Infinity Display Screen, Long Battery Life, Expandable Storage, US Version, Black
![Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study | Nature Medicine Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-02097-3/MediaObjects/41591_2022_2097_Fig1_HTML.png)
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study | Nature Medicine
![COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm705152a1_VaccineSafetyChildren_Image_31Dec21_1200x675.jpg)
COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR
![Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial - The Lancet Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial - The Lancet](https://www.thelancet.com/cms/attachment/4779d4de-27d1-495a-b273-cb7e4ac0e5b1/gr1.gif)
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial - The Lancet
![Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial - eClinicalMedicine Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial - eClinicalMedicine](https://www.thelancet.com/cms/asset/9cac4e71-ee77-472e-88a5-e6c316c904ac/gr1.jpg)
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial - eClinicalMedicine
![Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center | Scientific Reports Therapeutic plasma exchange in multiple sclerosis patients with an aggressive relapse: an observational analysis in a high-volume center | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-23356-w/MediaObjects/41598_2022_23356_Fig1_HTML.png)